论文信息 - Benefits of vascular normalization are dose and time dependent--letter.

Benefits of vascular normalization are dose and time dependent--letter.

Arjaans and colleagues reported that treatment with the anti-VEGF antibody bevacizumab hampers antibody uptake in an ectopic xenograft model of human ovarian cancer in mice ([1][1]). They found that bevacizumab decreased vessel number and increased pericyte coverage and concluded that treatment-

[1] R. Jain,et al. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy , 2012, Proceedings of the National Academy of Sciences.

[2] R. Jain,et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.

[3] R. Jain. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4] Marjolijn N Lub-de Hooge,et al. Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake. , 2013, Cancer research.

[5] M. Sliwkowski,et al. Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model , 2012, Molecular Cancer Therapeutics.